Aldose reductase

An aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia

Minoru Kawamura, Graeme Eisenhofer, Irwin J. Kopin, Peter F Kador, Yong S. Lee, Shigeki Fujisawa, Sanai Sato

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The neurotransmitter norepinephrine is metabolized by monoamine oxidase into an aldehyde intermediate that is further metabolized to the stable glycol derivative, 3,4-dihydroxyphenylglycol (DHPG). In this study, the possible role of aldose reductase in reducing this aldehyde intermediate in human sympathetic neurons has been examined. DHPG is formed when norepinephrine is incubated with aldose reductase in the presence of monoamine oxidase. DHPG metabolism is inhibited by the monoamine oxidase inhibitor, pargyline which prevents the deamination of norepinephrine, and by the aldose reductase inhibitor AL 1576, which inhibits DHPG formation without affecting the deamination of norepinephrine. Although similar formation of DHPG was observed with human liver aldehyde reductase, the production of DHPG was more effective with aldose reductase than aldehyde reductase. Two peaks of reductase activity corresponding to aldose reductase and aldehyde reductase were observed when sympathetic ganglia were chromatofocused. Molecular modeling studies indicate that the energy-minimized structure of 3,4-dihydroxymandelaldehyde bound to aldose reductase is similar to that of glyceraldehyde where the 2′-hydroxyl group forms hydrogen bonds with Trp111 and NADPH. These results suggest that aldose reductase may be important in metabolizing the potentially toxic aldehyde intermediate formed from norepinephrine in human sympathetic ganglia.

Original languageEnglish (US)
Pages (from-to)131-139
Number of pages9
JournalAutonomic Neuroscience: Basic and Clinical
Volume96
Issue number2
DOIs
StatePublished - Mar 18 2002

Fingerprint

Aldehyde Reductase
Sympathetic Ganglia
Aldehydes
Norepinephrine
Enzymes
Deamination
Monoamine Oxidase
Glyceraldehyde
Pargyline
Glycols
Monoamine Oxidase Inhibitors
Poisons
NADP
Hydroxyl Radical
Neurotransmitter Agents
Hydrogen
Oxidoreductases
Neurons

Keywords

  • 3,4-Dihydroxyphenylglycol
  • Aldehyde reductase
  • Aldose reductase
  • Norepinephrine
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Aldose reductase : An aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia. / Kawamura, Minoru; Eisenhofer, Graeme; Kopin, Irwin J.; Kador, Peter F; Lee, Yong S.; Fujisawa, Shigeki; Sato, Sanai.

In: Autonomic Neuroscience: Basic and Clinical, Vol. 96, No. 2, 18.03.2002, p. 131-139.

Research output: Contribution to journalArticle

Kawamura, Minoru ; Eisenhofer, Graeme ; Kopin, Irwin J. ; Kador, Peter F ; Lee, Yong S. ; Fujisawa, Shigeki ; Sato, Sanai. / Aldose reductase : An aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia. In: Autonomic Neuroscience: Basic and Clinical. 2002 ; Vol. 96, No. 2. pp. 131-139.
@article{e5f3c7171ba44eb48fb5941154af170b,
title = "Aldose reductase: An aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia",
abstract = "The neurotransmitter norepinephrine is metabolized by monoamine oxidase into an aldehyde intermediate that is further metabolized to the stable glycol derivative, 3,4-dihydroxyphenylglycol (DHPG). In this study, the possible role of aldose reductase in reducing this aldehyde intermediate in human sympathetic neurons has been examined. DHPG is formed when norepinephrine is incubated with aldose reductase in the presence of monoamine oxidase. DHPG metabolism is inhibited by the monoamine oxidase inhibitor, pargyline which prevents the deamination of norepinephrine, and by the aldose reductase inhibitor AL 1576, which inhibits DHPG formation without affecting the deamination of norepinephrine. Although similar formation of DHPG was observed with human liver aldehyde reductase, the production of DHPG was more effective with aldose reductase than aldehyde reductase. Two peaks of reductase activity corresponding to aldose reductase and aldehyde reductase were observed when sympathetic ganglia were chromatofocused. Molecular modeling studies indicate that the energy-minimized structure of 3,4-dihydroxymandelaldehyde bound to aldose reductase is similar to that of glyceraldehyde where the 2′-hydroxyl group forms hydrogen bonds with Trp111 and NADPH. These results suggest that aldose reductase may be important in metabolizing the potentially toxic aldehyde intermediate formed from norepinephrine in human sympathetic ganglia.",
keywords = "3,4-Dihydroxyphenylglycol, Aldehyde reductase, Aldose reductase, Norepinephrine, Sympathetic nervous system",
author = "Minoru Kawamura and Graeme Eisenhofer and Kopin, {Irwin J.} and Kador, {Peter F} and Lee, {Yong S.} and Shigeki Fujisawa and Sanai Sato",
year = "2002",
month = "3",
day = "18",
doi = "10.1016/S1566-0702(01)00385-X",
language = "English (US)",
volume = "96",
pages = "131--139",
journal = "Autonomic Neuroscience: Basic and Clinical",
issn = "1566-0702",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Aldose reductase

T2 - An aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia

AU - Kawamura, Minoru

AU - Eisenhofer, Graeme

AU - Kopin, Irwin J.

AU - Kador, Peter F

AU - Lee, Yong S.

AU - Fujisawa, Shigeki

AU - Sato, Sanai

PY - 2002/3/18

Y1 - 2002/3/18

N2 - The neurotransmitter norepinephrine is metabolized by monoamine oxidase into an aldehyde intermediate that is further metabolized to the stable glycol derivative, 3,4-dihydroxyphenylglycol (DHPG). In this study, the possible role of aldose reductase in reducing this aldehyde intermediate in human sympathetic neurons has been examined. DHPG is formed when norepinephrine is incubated with aldose reductase in the presence of monoamine oxidase. DHPG metabolism is inhibited by the monoamine oxidase inhibitor, pargyline which prevents the deamination of norepinephrine, and by the aldose reductase inhibitor AL 1576, which inhibits DHPG formation without affecting the deamination of norepinephrine. Although similar formation of DHPG was observed with human liver aldehyde reductase, the production of DHPG was more effective with aldose reductase than aldehyde reductase. Two peaks of reductase activity corresponding to aldose reductase and aldehyde reductase were observed when sympathetic ganglia were chromatofocused. Molecular modeling studies indicate that the energy-minimized structure of 3,4-dihydroxymandelaldehyde bound to aldose reductase is similar to that of glyceraldehyde where the 2′-hydroxyl group forms hydrogen bonds with Trp111 and NADPH. These results suggest that aldose reductase may be important in metabolizing the potentially toxic aldehyde intermediate formed from norepinephrine in human sympathetic ganglia.

AB - The neurotransmitter norepinephrine is metabolized by monoamine oxidase into an aldehyde intermediate that is further metabolized to the stable glycol derivative, 3,4-dihydroxyphenylglycol (DHPG). In this study, the possible role of aldose reductase in reducing this aldehyde intermediate in human sympathetic neurons has been examined. DHPG is formed when norepinephrine is incubated with aldose reductase in the presence of monoamine oxidase. DHPG metabolism is inhibited by the monoamine oxidase inhibitor, pargyline which prevents the deamination of norepinephrine, and by the aldose reductase inhibitor AL 1576, which inhibits DHPG formation without affecting the deamination of norepinephrine. Although similar formation of DHPG was observed with human liver aldehyde reductase, the production of DHPG was more effective with aldose reductase than aldehyde reductase. Two peaks of reductase activity corresponding to aldose reductase and aldehyde reductase were observed when sympathetic ganglia were chromatofocused. Molecular modeling studies indicate that the energy-minimized structure of 3,4-dihydroxymandelaldehyde bound to aldose reductase is similar to that of glyceraldehyde where the 2′-hydroxyl group forms hydrogen bonds with Trp111 and NADPH. These results suggest that aldose reductase may be important in metabolizing the potentially toxic aldehyde intermediate formed from norepinephrine in human sympathetic ganglia.

KW - 3,4-Dihydroxyphenylglycol

KW - Aldehyde reductase

KW - Aldose reductase

KW - Norepinephrine

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0037128460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037128460&partnerID=8YFLogxK

U2 - 10.1016/S1566-0702(01)00385-X

DO - 10.1016/S1566-0702(01)00385-X

M3 - Article

VL - 96

SP - 131

EP - 139

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

SN - 1566-0702

IS - 2

ER -